Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer].
Westeel V, Lebitasy MP, Mercier M, Girard P, Barlesi F, Blanchon F, Tredaniel J, Bonnette P, Woronoff-Lemsi MC, Breton JL, Azarian R, Falcoz PE, Friard S, Geriniere L, Laporte S, Lemarie E, Quoix E, Zalcman G, Guigay J, Morin F, Milleron B, Depierre A; Intergroupe Francophone de Cancerologie Thoracique (IFCT). Westeel V, et al. Among authors: laporte s. Rev Mal Respir. 2007 May;24(5):645-52. doi: 10.1016/s0761-8425(07)91135-3. Rev Mal Respir. 2007. PMID: 17519819 Clinical Trial. French.
[Recommendations of good practice for the management of thromboembolic venous disease in adults. Short version].
Sanchez O, Benhamou Y, Bertoletti L, Constant J, Couturaud F, Delluc A, Elias A, Fischer AM, Frappé P, Gendron N, Girard P, Godier A, Gut-Gobert C, Laporte S, Mahé I, Mauge L, Meneveau N, Meyer G, Mismetti P, Parent F, Pernod G, Quéré I, Revel MP, Roy PM, Salaün PY, Smadja DM, Sevestre MA. Sanchez O, et al. Among authors: laporte s. Rev Mal Respir. 2019 Feb;36(2):249-283. doi: 10.1016/j.rmr.2019.01.003. Epub 2019 Feb 22. Rev Mal Respir. 2019. PMID: 30799126 French. No abstract available.
[Recommendations for best practice in the management of venous thromboembolic disease in adults. Long version].
Sanchez O, Benhamou Y, Bertoletti L, Constans J, Couturaud F, Delluc A, Elias A, Fischer AM, Frappé P, Gendron N, Girard P, Godier A, Gut-Gobert C, Laporte S, Mahé I, Mauge L, Meneveau N, Meyer G, Mismetti P, Parent F, Pernod G, Quéré I, Revel MP, Roy PM, Salaün PY, Smadja DM, Sevestre MA. Sanchez O, et al. Among authors: laporte s. Rev Mal Respir. 2021 Apr;38 Suppl 1:e1-e6. doi: 10.1016/j.rmr.2019.05.038. Epub 2019 Jul 4. Rev Mal Respir. 2021. PMID: 31280989 French. No abstract available.
[What duration of anticoagulant treatment for PE/proximal DVT?].
Couturaud F, Girard P, Laporte S, Sanchez O; groupe de travail Recommandations de bonne pratique pour la prise en charge de la MVTE. Couturaud F, et al. Among authors: laporte s. Rev Mal Respir. 2021 Apr;38 Suppl 1:e99-e112. doi: 10.1016/j.rmr.2019.05.022. Epub 2019 Nov 9. Rev Mal Respir. 2021. PMID: 31711819 French. No abstract available.
[Treatment of cancer associated thrombosis. 2019 update of the French guidelines].
Mahé I, Meyer G, Girard P, Bertoletti L, Laporte S, Couturaud F, Mismetti P, Sanchez O; pour le groupe de travail Recommandations de bonne pratique pour la prise en charge de la MVTE. Mahé I, et al. Among authors: laporte s. Rev Mal Respir. 2021 Apr;38(4):427-437. doi: 10.1016/j.rmr.2021.03.001. Epub 2021 Apr 12. Rev Mal Respir. 2021. PMID: 33858733 French. No abstract available.
Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis: specificity of symptoms and perfusion defects at baseline and during anticoagulant therapy.
Girard P, Decousus M, Laporte S, Buchmuller A, Hervé P, Lamer C, Parent F, Tardy B; PREPIC Study Group. Girard P, et al. Among authors: laporte s. Am J Respir Crit Care Med. 2001 Sep 15;164(6):1033-7. doi: 10.1164/ajrccm.164.6.2101045. Am J Respir Crit Care Med. 2001. PMID: 11587992 Clinical Trial.
[Guidelines for good clinical practice: prevention and treatment of venous thromboembolism in medical patients].
Mismetti P, Baud JM, Becker F, Belmahdi F, Blanchard P, Constans J, Couturaud F, Debourdeau P, Drouet L, Dumarcet N, Ferrari E, Galanaud JP, Girard P, Hay B, Laporte S, Laroche JP, Leizorovicz A, Liard F, Mahé I, Meyer G, Oger E, Parent F, Quéré I, Samama M; Agence française de sécurité sanitaire des produits de santé. Mismetti P, et al. Among authors: laporte s. J Mal Vasc. 2010 Jun;35(3):127-36. doi: 10.1016/j.jmv.2009.12.002. Epub 2010 Feb 16. J Mal Vasc. 2010. PMID: 20163928 French. No abstract available.
[What are the options for the initial anticoagulant treatment of a PE and a proximal DVT?].
Couturaud F, Fischer AM, Laporte S, Sanchez O; groupe de travail Recommandations de bonne pratique pour la prise en charge de la MVTE. Couturaud F, et al. Among authors: laporte s. Rev Mal Respir. 2021 Apr;38 Suppl 1:e41-e52. doi: 10.1016/j.rmr.2019.05.003. Epub 2019 Nov 4. Rev Mal Respir. 2021. PMID: 31699457 French. No abstract available.
[Translation into French and republication of: "Anticoagulant treatment of cancer-associated thromboembolism"].
Mahé I, Mayeur D, Couturaud F, Scotté F, Benhamou Y, Benmaziane A, Bertoletti L, Laporte S, Girard P, Mismetti P, Sanchez O; Groupe de travail INNOVTE CAT. Mahé I, et al. Among authors: laporte s. Rev Med Interne. 2024 Apr;45(4):210-225. doi: 10.1016/j.revmed.2024.04.004. Epub 2024 Apr 26. Rev Med Interne. 2024. PMID: 38677976 Review. French.
413 results